Anti-thrombotic therapy in cancer patients (Q35593973)

9 August 2017

1 reference

title

Anti-thrombotic therapy in cancer patients (English)

1 reference

9 August 2017

Agnes Y Y Lee

1

1 reference

PubMed ID

14640920

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Expert Opinion on Pharmacotherapy

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

12

1 reference

9 August 2017

2213-2220

1 reference

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

9 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Anticoagulants in thrombosis and cancer: the missing link

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

The role of the coagulation system in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Venous thromboembolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

Prognosis of Cancers Associated with Venous Thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2213

10.1517/14656566.4.12.2213

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14640920